Compatible concurrent administration of yellow fever 17D vaccine with oral, live, attenuated p6olera CVD103-HgR and typhoid ty21a vaccines.
Tsai
T F
TF
Kollaritsch
H
H
Que
J U
JU
Cropp
C B
CB
Kunz
C
C
Wiedermann
G
G
Herzog
C
C
Cryz
S J
SJ
D002771:Cholera / Q000517:prevention & control*; D022121:Cholera Vaccines / Q000008:administration & dosage* / Q000276:immunology; D004347:Drug Interactions; D006801:Humans; D011135:Polysaccharides, Bacterial / Q000008:administration & dosage* / Q000276:immunology; D014435:Typhoid Fever / Q000517:prevention & control*; D014436:Typhoid-Paratyphoid Vaccines / Q000008:administration & dosage* / Q000276:immunology; D014613:Vaccines, Attenuated / Q000008:administration & dosage; D014765:Viral Vaccines / Q000008:administration & dosage*; D015004:Yellow Fever / Q000517:prevention & control*; D015005:Yellow fever virus / Q000276:immunology
D022121:Cholera Vaccines; D011135:Polysaccharides, Bacterial; C072772:Ty21a typhoid vaccine; D014436:Typhoid-Paratyphoid Vaccines; D014613:Vaccines, Attenuated; D014765:Viral Vaccines